Stocks That Hit 52-Week Highs On Friday
On Friday morning, 154 companies achieved new highs for the year.
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs.
JP Morgan Downgrades ResMed to Neutral, Raises Price Target to $246
JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral and raises the price target from $245 to $246.
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday morning, 54 companies achieved new highs for the year.
Stocks That Hit 52-Week Highs On Monday
On Monday morning, 20 companies achieved new highs for the year.
Stocks That Hit 52-Week Highs On Friday
During Friday's morning trading, 90 companies set new 52-week highs.
The Daily Biotech Pulse: Priority Review For Amgen’s Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.